HBXIP activates the PPARδ/NF-κB feedback loop resulting in cell proliferation

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Hepatitis B X-interacting protein (HBXIP) is implicated in cancer progression, but its precise mechanisms remain elusive.
• Understanding HBXIP's role is crucial for developing targeted therapies for colonic cancer.

Purpose of the Study:

• To elucidate the molecular mechanisms by which HBXIP influences colonic cancer progression.
• To investigate the relationship between HBXIP, PPARδ, and NF-κB in colonic cancer cells and clinical samples.

Main Methods:

• Gene and protein expression analysis in colonic cancer cells (SW480, HT-29).
• Chromatin immunoprecipitation and luciferase reporter assays to assess transcriptional regulation.
• Co-immunoprecipitation and immunofluorescence to study protein-protein interactions.
• Analysis of clinical colonic carcinoma specimens.

Main Results:

• HBXIP upregulates both gene and protein expression of peroxisome proliferator-activated receptor-δ (PPARδ).
• HBXIP directly binds to the PPARδ promoter and activates its transcription in an NF-κB (p65)-dependent manner.
• A positive feedback loop exists where PPARδ enhances NF-κB/p65 expression.
• Both HBXIP and PPARδ are overexpressed in colonic carcinoma, correlating with advanced stage and metastasis.

Conclusions:

• HBXIP acts as a co-activator, establishing a positive feedback loop between NF-κB and PPARδ, driving colonic cancer cell proliferation.
• HBXIP represents a promising therapeutic target for colonic cancer treatment.